ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is a clinical trial[1].
Key Facts
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Belgium[2].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Canada[3].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Germany[4].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Japan[5].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Netherlands[6].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade is in the country of Spain[7].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's instance of is recorded as clinical trial[8].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's start time is recorded as +2018-02-15T00:00:00Z[9].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's end time is recorded as +2022-07-29T00:00:00Z[10].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's sponsor is recorded as Novartis[11].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's main subject is recorded as hepatitis A[12].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's main subject is recorded as hepatitis[13].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's number of participants is recorded as {'unit': '1', 'amount': '+80'}[14].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's title is recorded as A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of VAY736 in Autoimmune Hepatitis[15].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's short name is recorded as AMBER[16].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[17].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's ClinicalTrials.gov ID is recorded as NCT03217422[18].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[19].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's clinical trial phase is recorded as phase II clinical trial[20].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's clinical trial phase is recorded as phase III clinical trial[21].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's research site is recorded as Novartis[22].
- ADCC Mediated B-Cell dEpletion and BAFF-R Blockade's study type is recorded as interventional study[23].